๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

โœ Scribed by Yonemori, K; Ando, M; Yunokawa, M; Hirata, T; Kouno, T; Shimizu, C; Tamura, K; Katsumata, N; Hirakawa, A; Matsumoto, K

Book ID
109999908
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
136 KB
Volume
100
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of carboplatin, gemcitabi
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site
โœ Bryan J. Schneider; Basil El-Rayes; Jeffery H. Muler; Philip A. Philip; Gregory ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. The purposes of this study were to evaluate efficacy and toxicity of the combination of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site (CUP). ## METHODS. Patients with CUP received carboplatin AUC 5 mg/mL a minute intraven